Search for: "The Active v. United States" Results 81 - 100 of 18,115
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Apr 2024, 4:00 am by Administrator
In the recent case (Taylor v. [read post]
1 Apr 2024, 3:00 am by Jeff Welty
Pachtman, 424 U.S. 409 (1976), the Supreme Court of the United States considered prosecutorial immunity in the context of section 1983 actions. [read post]
30 Mar 2024, 9:53 am by Larry
United States in which the importer challenged the tariff classification of several versions of the gaseous tritium light sources ("GTLS"). [read post]
29 Mar 2024, 7:28 pm
In 2016 the United States Government published its first National Action Plan on Responsible Business Conduct. [read post]
Declaring the NLRB’s rationale to be “nonsense,” on March 26, 2024, a unanimous three-judge panel for the United States Court of Appeals for the District of Columbia in Stern Produce Company Inc v. [read post]
29 Mar 2024, 5:55 am by Vito Todeschini
However, in their comments submitted in December 2023 in preparation of the Sixth Committee’s second resumed session, certain States contended that territorial and active personality jurisdiction should be accorded priority over other bases (Israel, paras. 14-15; Singapore, para. 6; Türkiye, pp. 2, 4; United States, p. 6). [read post]
28 Mar 2024, 12:25 pm by David Klein
On March 15, 2024, a United States District Court for the Southern District of California granted Defendant’s Motion to Dismiss in the matter of Rodriguez v. [read post]
27 Mar 2024, 5:26 pm by Andrew Crocker
United States, “A person does not surrender all Fourth Amendment protection by venturing into the public sphere. [read post]
27 Mar 2024, 4:46 pm by Dennis Crouch
The statute states: It shall not be an act of infringement to make, use, offer to sell, or sell within the United States or import into the United States a patented invention . . . solely for uses reasonably related to the development and submission of information under a Federal law which regulates the manufacture, use, or sale of drugs or veterinary biological products. 35 U.S.C. [read post]